AxoGen, Inc. Forecast, price target & analysts
AxoGen, Inc. Target price 2025 - Analyst rating & recommendation
AxoGen, Inc. Classifications & Recommendation:
AxoGen, Inc. Price Target
| Target Price | $26.01 |
| Price | $15.71 |
| Potential |
65.56%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target AxoGen, Inc. 2026 .
The average AxoGen, Inc. target price is $26.01.
This is
65.56%
register free of charge
$31.50
100.51%
register free of charge
$20.20
28.58%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend AxoGen, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AxoGen, Inc. stock has an average upside potential 2026 of
65.56%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 187.34 | 224.15 |
| 17.82% | 19.65% | |
| EBITDA Margin | 2.43% | 11.17% |
| 124.27% | 359.91% | |
| Net Margin | -5.32% | 5.31% |
| 61.08% | 199.88% |
10 Analysts have issued a sales forecast AxoGen, Inc. 2025 . The average AxoGen, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an AxoGen, Inc. EBITDA forecast 2025. The average AxoGen, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 AxoGen, Inc. Analysts have issued a net profit forecast 2025. The average AxoGen, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.23 | 0.26 |
| 54.90% | 213.04% | |
| P/E | 60.40 | |
| EV/Sales | 3.31 |
10 Analysts have issued a AxoGen, Inc. forecast for earnings per share. The average AxoGen, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current AxoGen, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Mar 05 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 05 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 26 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 26 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 03 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
